ETF Managers Group’s Inovio Pharmaceuticals INO Stock Holding History

ETF Managers Group’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$70.8K	Buy	7,197 +2,014	+39%	+$34.3K	﹤0.01%	654
2022 Q4	$97K	Sell	5,183 -950	-15%	-$21.5K	﹤0.01%	492
2022 Q3	$127K	Buy	6,133 +103	+2%	+$2.64K	﹤0.01%	639
2022 Q2	$130K	Buy	6,030 +712	+13%	+$20.1K	﹤0.01%	672
2022 Q1	$233K	Buy	5,318 +19	+0.4%	+$856	﹤0.01%	593
2021 Q4	$330K	Sell	5,299 -1,102	-17%	-$88.3K	0.01%	588
2021 Q3	$558K	Buy	6,401 +1,254	+24%	+$126K	0.01%	507
2021 Q2	$584K	Sell	5,147 -159	-3%	-$15.3K	0.01%	477
2021 Q1	$561K	Sell	5,306 -1,561	-23%	-$205K	0.01%	398
2020 Q4	$742K	Sell	6,867 -2,054	-23%	-$273K	0.02%	272
2020 Q3	$1.21M	Buy	8,921 +3,753	+73%	+$783K	0.04%	188
2020 Q2	$1.97M	Buy	+5,168	New	+$830K	0.07%	144

Other funds holding INO

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ETF Managers Group's INO Position: Q1 2023 in Review

ETF Managers Group increased its Inovio Pharmaceuticals (INO) stake by 39% in Q1 2023, buying an estimated $34.3K and bringing the position to 7,197 shares worth $70.8K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

ETF Managers Group first reported a position in INO in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.97M in Q2 2020. 174 funds tracked by Wall St. Rank hold INO as of Q1 2023.

ETF Managers Group held 7,197 shares of Inovio Pharmaceuticals worth $70.8K as of Q1 2023.
ETF Managers Group bought 2,014 Inovio Pharmaceuticals shares in Q1 2023, an estimated $34.3K.
Inovio Pharmaceuticals made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #654 holding.
ETF Managers Group first reported a position in Inovio Pharmaceuticals in Q2 2020 and has held it in 12 quarters since.
ETF Managers Group's Inovio Pharmaceuticals position peaked at $1.97M in Q2 2020.
174 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.